Theranostic Information Provided by FMTVDM ©ⓟ; B.E.S.T ©ⓟ. Imaging
Advances in Hematology and Oncology Research · 2019
DOI: 10.33140/ahor.02.01.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Hematology and Oncology Research, 2019. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Until quite recently, diagnostic imaging has relied upon “qualitative” imaging limited by the ability to define disease as either present or absent. The first marker that you are using a “qualitative” test is a discussion of sensitivity, the ability to find disease when present and specificity, the ability to exclude disease when absent [1-9]. This yes/no approach to medicine reflects the limitations qualitatively imposed upon us despite the understanding that tissues don’t simply exist in either a “normal” or “diseased” state but rather a transition occurs as the genetic and environmental factors influencing tissues results in transitional changes, transitional changes which can now be fully appreciated and measured [1-9].
Zitieren
APA
(2019). Theranostic Information Provided by FMTVDM ©ⓟ; B.E.S.T ©ⓟ. Imaging. Advances in Hematology and Oncology Research. https://doi.org/10.33140/ahor.02.01.01
Vancouver
Theranostic Information Provided by FMTVDM ©ⓟ; B.E.S.T ©ⓟ. Imaging. Advances in Hematology and Oncology Research. 2019. doi:10.33140/ahor.02.01.01
BibTeX
@article{euvimed2019,
title = {Theranostic Information Provided by FMTVDM ©ⓟ; B.E.S.T ©ⓟ. Imaging},
journal = {Advances in Hematology and Oncology Research},
year = {2019},
doi = {10.33140/ahor.02.01.01}
}
EUVIMED